• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

焦磷酸测序和 QMC-PCR 联合高分辨率熔解分析用于 KRAS/BRAF 基因突变检测的比较分析。

Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection.

机构信息

Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, UK.

出版信息

Int J Exp Pathol. 2010 Dec;91(6):500-5. doi: 10.1111/j.1365-2613.2010.00733.x. Epub 2010 Sep 7.

DOI:10.1111/j.1365-2613.2010.00733.x
PMID:21199003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3010548/
Abstract

Mutation detection is important in cancer management. Several methods are available of which high resolution melting (HRM) analysis and pyrosequencing are the most versatile. We undertook a comparative analysis of these techniques. The methods are: To compare the limit of detection (LOD), mutations in KRAS (codon 12/13 hotspot) and BRAF (V600E hotspot) were tested. DNA mixtures containing mutant alleles at a frequency of around 25%/12.5%/6%/3%/ 1.5%/0.8% were analysed. To compare frequency of mutation detection, 22 DNA samples (nine high quality samples from cell lines, 13 low quality samples from formalin-fixed paraffin-embedded tissue) were tested for three hotspots in KRAS (codons 12/13, 61 and 146) and two hotspots in BRAF (V600E and exon 11). HRM analysis of KRAS (codon12/13) and BRAF (V600E) showed that 3% and 1.5% mutant alleles respectively could be reliably detected whilst pyrosequencing reliably detected 6% mutant alleles in each case. Of 110 tests performed on 22 DNA samples, in 109 cases HRM and pyrosequencing gave identical results. Two of the samples tested had previously been called as wild type for KRAS by direct Sanger sequencing but were found to be mutant by both HRM and pyrosequencing. Both HRM and pyrosequencing can detect small numbers of mutant alleles although HRM has a lower limit of detection. Both are suitable for use in mutation detection and are both more sensitive than Sanger sequencing.

摘要

突变检测在癌症管理中很重要。有几种方法可供选择,其中高分辨率熔解(HRM)分析和焦磷酸测序是最通用的。我们对这些技术进行了比较分析。这些方法是:为了比较检测限(LOD),对 KRAS(密码子 12/13 热点)和 BRAF(V600E 热点)的突变进行了测试。分析了含有突变等位基因频率约为 25%/12.5%/6%/3%/1.5%/0.8%的 DNA 混合物。为了比较突变检测频率,对 22 个 DNA 样本(来自细胞系的 9 个高质量样本,来自福尔马林固定石蜡包埋组织的 13 个低质量样本)进行了三个 KRAS(密码子 12/13、61 和 146)和两个 BRAF(V600E 和外显子 11)热点的突变检测。KRAS(密码子 12/13)和 BRAF(V600E)的 HRM 分析表明,分别可以可靠地检测到 3%和 1.5%的突变等位基因,而焦磷酸测序在每种情况下都可以可靠地检测到 6%的突变等位基因。在对 22 个 DNA 样本进行的 110 次测试中,HRM 和焦磷酸测序在 109 次测试中给出了相同的结果。在测试的两个样本中,先前通过直接 Sanger 测序被称为 KRAS 野生型,但通过 HRM 和焦磷酸测序均被发现为突变型。HRM 和焦磷酸测序都可以检测少量的突变等位基因,尽管 HRM 的检测下限较低。这两种方法都适用于突变检测,并且都比 Sanger 测序更敏感。

相似文献

1
Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection.焦磷酸测序和 QMC-PCR 联合高分辨率熔解分析用于 KRAS/BRAF 基因突变检测的比较分析。
Int J Exp Pathol. 2010 Dec;91(6):500-5. doi: 10.1111/j.1365-2613.2010.00733.x. Epub 2010 Sep 7.
2
Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.采用高分辨率熔解分析和超深度焦磷酸测序法进行 KRAS、BRAF 和 EGFR 基因突变的临床药物基因组学检测。
BMC Cancer. 2011 Sep 24;11:406. doi: 10.1186/1471-2407-11-406.
3
KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.常规分子诊断中的 KRAS 和 BRAF 突变分析:三种检测方法在福尔马林固定、石蜡包埋肿瘤源性 DNA 上的比较。
J Mol Diagn. 2012 May-Jun;14(3):247-55. doi: 10.1016/j.jmoldx.2012.01.011. Epub 2012 Mar 14.
4
Characteristics and prevalence of KRAS, BRAF, and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwanese population.台湾地区人群应用高分辨率熔解曲线分析检测结直肠癌中 KRAS、BRAF 和 PIK3CA 基因突变的特征和流行率。
Clin Chim Acta. 2012 Oct 9;413(19-20):1605-11. doi: 10.1016/j.cca.2012.04.029. Epub 2012 May 8.
5
Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients.结直肠癌患者循环肿瘤细胞中KRAS和BRAF突变的非侵入性灵敏检测
Mol Oncol. 2015 Apr;9(4):850-60. doi: 10.1016/j.molonc.2014.12.011. Epub 2015 Jan 7.
6
Duplex reverse-hybridization assay for the simultaneous detection of KRAS/BRAF mutations in FFPE-extracted genomic DNA from colorectal cancer specimens.用于同时检测结直肠癌标本中 FFPE 提取基因组 DNA 中 KRAS/BRAF 突变的双杂交反向杂交检测。
Dis Markers. 2013;34(3):171-7. doi: 10.3233/DMA-120960.
7
Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue.晚期结直肠癌中 KRAS、BRAF 和 PIK3CA 基因突变的频率:肽核酸介导的 PCR 夹心法与直接测序在福尔马林固定、石蜡包埋组织中的比较。
Pathol Res Pract. 2011 Dec 15;207(12):762-8. doi: 10.1016/j.prp.2011.10.002. Epub 2011 Nov 8.
8
[Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].实时定量PCR-桑格测序法与TaqMan探针法检测结直肠癌KRAS/BRAF突变的比较分析
Zhonghua Bing Li Xue Za Zhi. 2014 Feb;43(2):77-82.
9
Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.用于检测结直肠癌福尔马林固定石蜡包埋组织样本中 KRAS 突变(密码子 12/13 和 61)的 PCR 检测分析性能。
Virchows Arch. 2012 Feb;460(2):141-9. doi: 10.1007/s00428-011-1180-0. Epub 2011 Dec 16.
10
Quick-multiplex-consensus (QMC)-PCR followed by high-resolution melting: a simple and robust method for mutation detection in formalin-fixed paraffin-embedded tissue.快速多重共识聚合酶链式反应(QMC-PCR)结合高分辨率熔解曲线分析:一种简单而强大的福尔马林固定石蜡包埋组织中基因突变检测方法。
J Clin Pathol. 2010 Feb;63(2):134-40. doi: 10.1136/jcp.2009.070508.

引用本文的文献

1
Evaluation of droplet digital PCR and next generation sequencing for characterizing DNA reference material for KRAS mutation detection.评估液滴数字 PCR 和下一代测序在 KRAS 基因突变检测中对 DNA 参考物质进行特征分析的应用。
Sci Rep. 2018 Nov 30;8(1):9650. doi: 10.1038/s41598-018-27368-3.
2
RAS testing in metastatic colorectal cancer: advances in Europe.转移性结直肠癌中的RAS检测:欧洲的进展
Virchows Arch. 2016 Apr;468(4):383-96. doi: 10.1007/s00428-015-1876-7. Epub 2015 Nov 16.
3
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer.免疫组织化学和分子方法相结合可提高甲状腺乳头状癌中BRAF突变的高灵敏度检测。
Endocrine. 2016 Sep;53(3):672-80. doi: 10.1007/s12020-015-0720-9. Epub 2015 Aug 22.
4
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies.BRAF 突变型黑色素瘤:治疗方法、耐药机制和诊断策略。
Onco Targets Ther. 2015 Jan 16;8:157-68. doi: 10.2147/OTT.S39096. eCollection 2015.
5
KRAS Testing: A Tool for the Implementation of Personalized Medicine.KRAS检测:个性化医疗实施的一种工具。
Genes Cancer. 2012 Jul;3(7-8):459-66. doi: 10.1177/1947601912460547.
6
Detection of BRAF(V600E) Mutations in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-Time PCR: A Comparison with Direct Sequencing.肽核酸钳实时荧光定量PCR检测甲状腺乳头状癌中BRAF(V600E)突变:与直接测序法的比较
Korean J Pathol. 2012 Feb;46(1):61-7. doi: 10.4132/KoreanJPathol.2012.46.1.61. Epub 2012 Feb 23.
7
KRAS mutation testing in metastatic colorectal cancer.转移性结直肠癌的 KRAS 基因突变检测。
World J Gastroenterol. 2012 Oct 7;18(37):5171-80. doi: 10.3748/wjg.v18.i37.5171.
8
Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis.焦磷酸测序数据分析软件:用于 EGFR、KRAS 和 BRAF 基因突变分析的有用工具。
Diagn Pathol. 2012 May 28;7:56. doi: 10.1186/1746-1596-7-56.
9
KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues.配对的冷冻和福尔马林固定石蜡包埋(FFPE)结直肠癌组织中的KRAS突变检测
Int J Mol Sci. 2011;12(5):3191-204. doi: 10.3390/ijms12053191. Epub 2011 May 17.
10
Mutation scanning of peach floral genes.桃花色器官基因的突变扫描。
BMC Plant Biol. 2011 May 23;11:96. doi: 10.1186/1471-2229-11-96.

本文引用的文献

1
Quick-multiplex-consensus (QMC)-PCR followed by high-resolution melting: a simple and robust method for mutation detection in formalin-fixed paraffin-embedded tissue.快速多重共识聚合酶链式反应(QMC-PCR)结合高分辨率熔解曲线分析:一种简单而强大的福尔马林固定石蜡包埋组织中基因突变检测方法。
J Clin Pathol. 2010 Feb;63(2):134-40. doi: 10.1136/jcp.2009.070508.
2
A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting.一项多中心、盲法研究,旨在评估 KRAS 基因突变检测方法在临床环境中的应用。
J Mol Diagn. 2009 Nov;11(6):543-52. doi: 10.2353/jmoldx.2009.090057. Epub 2009 Oct 8.
3
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.KRAS密码子61、146以及BRAF突变预示着KRAS密码子12和13野生型转移性结直肠癌患者对西妥昔单抗联合伊立替康耐药。
Br J Cancer. 2009 Aug 18;101(4):715-21. doi: 10.1038/sj.bjc.6605177. Epub 2009 Jul 14.
4
Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.KRAS和BRAF中的伴随突变及剪接变体表明晚期结直肠癌中Ras/Raf信号通路存在复杂的扰动。
Gut. 2009 Sep;58(9):1234-41. doi: 10.1136/gut.2008.159137. Epub 2009 May 26.
5
Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissues.焦磷酸测序法检测福尔马林固定石蜡包埋肿瘤组织中的KRAS突变
Anal Biochem. 2009 Aug 15;391(2):166-8. doi: 10.1016/j.ab.2009.05.027. Epub 2009 May 21.
6
Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancers.新型焦磷酸测序分析在一组散发性结直肠癌中筛查BRAF和KRAS常见突变的应用
Diagn Mol Pathol. 2009 Jun;18(2):62-71. doi: 10.1097/PDM.0b013e318182af52.
7
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.西妥昔单抗与化疗联合作为转移性结直肠癌的初始治疗方案
N Engl J Med. 2009 Apr 2;360(14):1408-17. doi: 10.1056/NEJMoa0805019.
8
Monoclonal antibodies for cancer immunotherapy.用于癌症免疫治疗的单克隆抗体。
Lancet. 2009 Mar 21;373(9668):1033-40. doi: 10.1016/S0140-6736(09)60251-8.
9
The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability.假定的肿瘤修饰基因ATP5A1在人结肠癌细胞系中未发生突变,但表达水平与TP53突变及染色体不稳定性相关。
J Clin Pathol. 2009 Jul;62(7):598-603. doi: 10.1136/jcp.2009.064436. Epub 2009 Mar 3.
10
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.评估高分辨率熔解分析作为检测结直肠肿瘤中BRAF V600E突变的诊断工具。
J Mol Diagn. 2009 Mar;11(2):140-7. doi: 10.2353/jmoldx.2009.080100. Epub 2009 Feb 12.